Please login to the form below

Not currently logged in
Email:
Password:

Ovid Therapeutics

This page shows the latest Ovid Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Biotech leaders jump into US free speech debate

Biotech leaders jump into US free speech debate

Biotech leaders jump into US free speech debate. Senior officials from Alnylam, Decibel Therapeutics and more sign the letter in defence of free speech. ... Alnylam chief executive John Maraganore, Decibel Therapeutics’CEO Steve Holtzman, Acorda CEO

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics